Icecure Medical is trading at $1.25, up 8.35% in pre-market on October 8, with no clear company-specific catalyst identified. - Its latest located announcement was October 6, when IceCure added Legacy Health as a site in its FDA-approved ChoICE post-marketing study; this prior news is not a confirmed explanation for the current move. - Broader markets are lower, and trading activity details were not provided.